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SUMMARY 
Thirty four cases of endogenous major depression (RDC) have been studied in order to examine 
whether negative symptoms influence the outcome of depression, by comparing depressives with and without 
predominant negative symptoms, and by examining which negative symptoms have high percentage reduction in 
scores. Panents were rated on Scale for Assessment of Negative Symptoms (SANS) during their inclusion and later 
during one year followup. Complete recovery was seen in only 41 % of the cases. Depression with predominant 
negative symptoms had poorer outcome and did not respond to tricyclic anti-depressants alone. The results indicate-
that negative symptoms adversely influence the clinical outcome in depressed patients and could have a role in 
producing chronicity. 
Introduction 
' Negative symptoms should not be as-
sumed to be specific to schizophrenia or pa-
thognomonic of it. Many negative symp-
toms could be seen in patients with other 
diseases, particularly depression (Andrea-
sen 1982, Andrcasen and Oslen 1982, And-
reasen 1979, Pogue-Gcile and Harrow 
1984, Chaturvedi and Sarmukaddam 1985, 
1985a, Lewine 1983, Andrcasen and Alas-
ka 1 1983). Though these studies have been 
conducted to examine negative symptoms 
in depression, symptoms which have been 
considered as 'negative' have also been 
dealt with in most phenomenological, no-
sological and outcome studies on depres-
sion. The frequency, nature and prognostic 
value of some negative symptoms have 
been examined though the symptoms were 
not termed as 'negative symptoms'. Hamilton 
(1982), Nelson et al. (1984) and many other 
studies on cluster analysis have disco-
vered a retarded-endogenous-psychotic 
cluster which is more likely to have nega-
tive symptoms (Grinkeretal. 1961, Overall 
et al. 1966, Pilowsky et al. 1969, Fleiss ct al. 
1971, Paykel 1971, Byrne 1978, and Nel-
son and Charncy 1981). 
It is evident from the above men-
tioned studies that symptoms which are eli-
cited using the Scale for Assessment of Ne-
gative Symptoms (SANS) by Andreasen 
(1981) are probably cardinal features of 
psychotic depression, atleast during the 
acute phase of the illness. But, it needs to be 
emphasised that these might be indistingui-
shable from negative symptoms in schi-
zophrenia (Andreasen 1979, Chaturvedi 
and Sarmukaddam 1985). 
The association of negative symptoms 
with poor prognosis is already appreciated 
in schizophrenic patients (Andreasen 1982, 
Andreasen and Oslen 1982), in depressive 
patients also negative symptoms have been 
found to predict poor prognosis (Chatur-
vedi and Sarmukaddam 1985a, 1986). Cer-
tain negative symptoms have been found to 
be persistent in depression, though to a dif-
ferent degree as compared to schizophre-
nia. Pogue-Geile and I larrow (1984) found 
poverty of speech, flat affect, psychomotor 
retardation and a mildly high total negative 
symptom score during followup after 1 V. 
years. Similarly, Cassano et al. (1983) have 
described various types of residual states 
during recovery from depression, some of 
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which are decreased affective under invol-
vement in activities and loss of affective re-
silence. 
The objectives of this study were to 
examine whether negative symptoms inf-
luent t- the outcome of depression hy com-
parative evaluation of improvement in de-
pressives with and without predominant 
negative symptoms, and studying the alte-
ration in negauve symptoms during the fol-
lowup and their relationship with treat-
ment given. 
Material and Methods 
Sample consisted of patients diagnosed 
as definite, endogenous major depressive 
disorder according to Research and Diag-
nostic Criteria (Spiuer 1978), between 16-
55 years of age, cither sex, presenting for 
the first tune at the out patient clinic of Na-
tional Institute of Mental Health and 
Neuro Sciences, Bangalore, India. Conse-
cutive cases fulfilling the above criteria 
were included. I'aticnts with associated or-
ganic problems, alcoholism or drug abuse, 
pjst history of non-affective psychotic di-
sorder, and those who had received treat-
ment elsewhere tor the present episode • 
were excluded. The cases were assessed us-
ing the Scale for Assessment of Negative 
Symptoms at the time of entry into the stu-
dy. The scale has undergone inter-rater and 
test-retest reliability at this centre. Out-
come was rated on a 5-point Clinical Global 
Improvement Scale (C.C.I. - recovered, 
moderate improvement, minimal improve-
ment, no improvement, worsened). Out-
come and repeat SANS were rated 'blind' at 
the end of treatment or one year period, 
whichever was earlier. Treatment was not 
controlled and patients were treated 
according to the clinical practice with tri-
cyclic antidepressants (Imipramine com-
monly) to begin with and a combination of 
tricyclics with EC'T or other psychoactive 
drugs in patients who did not show adequ-
ate response. 
Clinical and demographic details were 
recorded on an interview protorma. Pa-
tients with predominant negative symp-
toms were compared with those depres-
sives who had fewer negative symptoms. 
The relationship between percentage re-
duction of subscale scores with duration of 
treatment was examined. 
Results 
34 cases fulfilling the criteria were inc-
luded into the study. The distribution of 
sample and its demographic and clinical 
characteristics have been given elsewhere 
(Chaturvedi and Sarmukaddam 1985). The 
duration of illness was less than 2 months in 
41 %, between 2 to 6 months in 35%, 6-12 
months in 18% and more than one year in 
6%. 
Table 1 
Clinical Details 
Durriiinn i'l Treatment 
Less than 2 months 
?. -6 months 
6-12 months 
/lMJ>ri>IYMi'N( ((, (M) 
Nil of MiKl 
Moderate 
c omplcte Recovery 
7 
18 
9 
10 
10 
U 
20.6 
52.9 
26.5 
29.4 
29.4 
41.2 
Table 1 gives the duration of treatment 
of the cases and clinical improvement. Ten 
patients (29.4 %) had minimal or no impro-
vement and 14(41.2%) showed complete 
recovery. Ten cases (29.4 %) had moderate 
improvement. 
Table 2 
Mean negative symptom scores during followup 
Sub Scale 
Affective flattening 
Alogia 
Avolition-apathy 
Anhedonia 
Inattention 
TOTAL SCORE' 
Inn 
fc.38± 
3.97 ± 
7.32 ± 
9.79 ± 
3.47 ± 
32 .38 ± 
ial 
5.72 
».08 
4.33 
3.87 
3.12 
14.82 
Followup "* 
2.47 ± 2.98 
0.91 ± 2.12 
1.47 ± 2.06 
2.66 ± 3.10 
0.41 ± 0.70 
7.53 ± 7.80 
*** (Difference between initial and followup scores 
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Table 2 shows the initial and later, mean 
negative symptom scores. It can be ob-
served that at one year followup mild nega-
tive symptoms persist. 
Table 3 
Relationship of improvement with treatment 
, , imipramine + ECT 
Improvement n Imipramine of £h„ Jrug| 
complete 14 14 0 
M.W or 
Moderate 20 9 11 
Fisher's exact probability - 0.00006 
Table 3 shows that of the.20 patients 
who did not achieve complete recovery 11 
had to be given ECT or other psychoactive 
agents also. There is a highly significant dif-
ference between improvement with the 
treatment modalities. On examining the re-
lationship between depression with predo-
minant negative symptoms and certain cli-
nical variables, it was observed that depres-
sion with negative symptoms significantly 
more often necessitated use of ECT or 
other psychoactive agents (P - .013), also 
the improvement was significantly poorer 
(P - .053) as compared to other depression 
categories (Table 4). In Table 5 the 
percentage reduction in negative symptom 
scores in those of who received treatment 
for more than or less than six months have 
been displayed. High reduction (>75% of 
the score) in all sub-scales except alogia was 
significantly more associated with lesser 
duration of treatment (less than six 
months). Patients requiring treatment for 
more than six months also showed high re-
duction in negative symptoms, but only in 
very few cases. 
Discussion 
The study has tried to focus attention on 
two relatively uncommon themes related 
to depression, negative symptoms and clini-
cal improvement. The results have shown 
lack of improvement or poor outcome in 
ten cases (29.4%), which is comparable to 
results of other studies (Kerr 1974, Murphy 
et al. 1974, Shobe et al. 1981), but is much 
higher than the figures reported by Toone 
(1979). Seven of these ten cases had very 
high scores on most subscales and also the 
total negative symptom score. Though the 
relationship between clinical improvement 
and duration of treatment or nature of 
treatment cannot he explicitly stated, it ap-
pears that the non-alleviation of symptoms 
has resulted in longer duration of treatment 
as well as use of a combination of tricyclics 
with ECT or other psycho-active agents as 
neuroleptics. Tricyclics were not combined 
with MAO inhibitors. Improvement has 
been poorer in those depression cases who 
had predominant negative symptoms. This 
corroborates our earlier reports that nega-
tive symptoms predict poorer outcome in 
depressive patients (Chaturvedi and Sarmu-
kaddam 1985a). 
Negative symptoms in depression per-
sist for a longer period of time, than do 
other symptoms and could possibly persist 
as residual features as observed by Pogue-
Geile and" Harrow (1983), and described in 
the review by Cassano et al. (1983). Mild 
symptoms were persisting in our cases also, 
as is evident from the negative symptom 
scores after treatment and at one year fol-
lowup. 
This study should raise interest regard-
ing other related areas. Do negative symp-
toms continue as post-depressive personal-
ity changes? Mayer (1975) described fea-
tures similar to the negative symptoms in 
post-depressive personality, but attributed 
them to the use of anti-dcprcssants. The 
role of anti-depressants can neither be im-
plicated nor ruled out by our results. It is 
worth mentioning that marked negative 
symptoms were present before anti-depres-
sants were given and negative symptoms 
did not increase after the therapy, in any of 
the cases. The role of negative symptoms in 308 DO NEGATIVE SYMPTOMS INFLUENCE OUTCOME OF DEPRESSION? 
Table 4 
Correlates of depression with predominant negative symptoms 
Depression without Depression with Fisher's exact 
n predominant negative predominant negative probability 
symptoms (n, - 20) (n, " 14) 
•Duration oj lllnen 
less than (> months 
More than 6 months 
Duration of Treatment 
Lets than 6 months 
More than 6 months 
Improvemen. 
Complete 
Mild or Moderate 
Medication Given 
Imipramine 
Imipramine • ECT or 
other drugs 
26 
a 
25 
9 
14 
20 
23 
11 
17 
3 
15 
5 
11 
9 
16 
3 
10 
4 
3 
11 
P - 0.161 
P - 0.560 
P - 0.053 
.. P - 0.013 
Table 5 
Percentage reduction in negative symptom scores and duration of treatment 
Ajjedive flattening 
Lets than 6 months 
more than 6 months 
Alofia 
Lest than 6 months 
Morelthan 6 months 
/Iro/i/ioH-a/iar/iy 
Less than 6 months 
More than 6 months 
Anhedonia 
Less than 6 months 
More than 6 months 
Inattention 
Lets than 6 months 
More than 6 months 
Total Negative Symptom S(ore 
Less than 6 months 
More than 6 months 
(n) 
(21) 
(9) 
(19) 
(6) 
(2t) 
(9) 
(25) 
(9) 
(19) 
(7) 
(25) 
(9) 
High 
reduction 
( > 75%) 
16 
3 
16 
4 
19 
5 
23 
2 
18 
4 
22 
2 
Low 
reduction 
(<75%) 
5 
6 
3 
2 
2 
4 
2 
7 
1 
3 
3 
7 
Fishet's 
Exact 
Probability 
P - 0.0355 
P - 0.3430 
P - 0.0492 
P - 0.0002 
P - 0.0468 
P - 0.0006 
(Difference in (n) is betausc certain patients did not exhibit the symptom during their inclusion, hence their 
percentage reduction has not been examined). SANTOSH K. CHATURVBDI AND S. B. SARMUKADDAM 309 
causing or manifesting as chronicity needs 
to be examined. 
It seems, negative symptoms influence 
the clinical outcome in depressed patients, 
but their exact etiopathogenesis is not 
clearly understood. They could have a role 
in production of post depressive personality 
and chronicity of depression. More re-
search of these areas could clarify these is-
sues. 
The implications of studying negative 
symptoms could have other far reaching 
significance. Afterall, there still exist great 
disagreements concerning the definition 
and sub-typing of depressive disorders 
(Andreasen 1982a) and negative symptoms 
might help in evolving a new classification 
of depression, as in case of schizophrenia. 
Study of negative symptoms in depression 
open further avenues to study prognosis of 
depression, predictive ability of negative 
symptoms as regards long term prognosis, 
responses to drugs and physical treatments 
or studying etiological aspects of affective 
disorders. It also provides another dimen-
sion to examine the relationship between 
schizophrenic and affective disorders, or 
schizo-affective psychosis in terms of nega-
tive symptoms. 
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